| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |